Luis D. Borrero-García, Ph.D. Email and Phone Number

I am a Cancer Biologist and Research Scientist at the University of Puerto Rico Comprehensive Cancer Center, with over ten years of experience in molecular cancer therapeutics. I hold a B.S. in Biotechnology from the Interamerican University of Puerto Rico-Arecibo Campus and a Ph.D. in Biochemistry from the University of Puerto Rico Medical Sciences Campus. During my Ph.D., I researched under Dr. Suranganie Dharmawardhane, focusing on resistance mechanisms to anti-EGFR/HER2 therapy in breast cancer. I completed postdoctoral training at the University of California, San Francisco (UCSF), in the Department of Radiation Oncology, studying TGFβ's role in preclinical intracranial brain tumor models.Previously, I served as the Director of Research and Development at MBQ Pharma in Puerto Rico, developing preclinical studies for MBQ-167, which is currently in clinical trials. My work there involved breast cancer therapeutics, in vivo models of breast cancer, and UPLC-MS/MS method development and validation. My experience includes working with Balb/C and C57BL/6 mice, establishing intracranial and subcutaneous tumor models, administering intraperitoneal treatments, imaging intracranial tumors, and collecting tumor and brain samples. Currently, my research focuses on understanding the incidence and mortality of colorectal cancer in Puerto Rico, the most common cancer type in the region.